You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中国医疗集团(08225.HK)中期纯利升5.85%至1549万元不派中期息
格隆汇 08-13 21:27

格隆汇8月13日丨中国医疗集团(08225.HK)公布,截至2019年6月30日止6个月,实现营业收入3141.1万元(人民币,下同),同比增长0.53%;毛利2551.1万元,同比增长0.26%;公司权益持有人应占纯利1549万元,同比增长5.85%;每股基本及摊薄盈利1.56分,不派中期股息。

上市后医学临床服务、临床研究、医学联络、和医疗市场服务收入约3099.7万元,占总收入的98.68%,对比去年同期2927.3万元,上升5.89%。本期间没有关联方收入。

集团对2019年以后的持续关连交易的批准非常期待,它对集团在收入和利润上会产生相当显着的积极影响。

随着中国医药企业商业模式的变化,中国医疗集团承担起了以CRO以及CSO模式组合替代传统CSO模式的责任。集团不断在增强市场推广能力及拓展市场网路方面做出投资,以中国医疗集团及子品牌喜恩万全、拜敏万全、健寿万全、悦戒烟在本土市场推出全价值链的专注治疗领域产品品类增值的业务模式;董事会也将按稳建的原则审核评估可能进行的专案或投资,务求提升集团业务表现及公司股东回报。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account